The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 4733 -4741
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Related articles in The JI
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kryczek, I.
Right arrow Articles by Zou, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kryczek, I.
Right arrow Articles by Zou, W.

Induction of IL-17+ T Cell Trafficking and Development by IFN-{gamma}: Mechanism and Pathological Relevance in Psoriasis1

Ilona Kryczek2,*, Allen T. Bruce2,{dagger}, Johann E. Gudjonsson{dagger}, Andrew Johnston{dagger}, Abhishek Aphale{dagger}, Linhua Vatan*, Wojciech Szeliga*, Yin Wang*, Yan Liu*, Theodore H. Welling*, James T. Elder3,{dagger},{ddagger},§ and Weiping Zou3,*

* Department of Surgery, {dagger} Department of Dermatology, {ddagger} Department of Radiation Oncology, § Department of Microbiology and Immunology, University of Michigan Medical School, and Ann Arbor Veterans Affairs Hospital, Ann Arbor, MI 48105

Th1 and Th17 T cells are often colocalized in pathological environments, yet Th1-derived IFN-{gamma} inhibits Th17 cell development in vitro. We explored the physiologic basis of this paradox in humans. In this study, we demonstrate increased the number of CD4+ and CD8+ IL-17+ T cells in skin lesions of psoriasis. Furthermore, we show that myeloid APCs potently support induction of IL-17+ T cells, and that this activity is greatly increased in psoriasis. We tested stimuli that might account for this activity. Th1 cells and IFN-{gamma} are increased in psoriatic blood and lesional skin. We show that IFN-{gamma} programs myeloid APCs to induce human IL-17+ T cells via IL-1 and IL-23. IFN-{gamma} also stimulates APC production of CCL20, supporting migration of IL-17+ T cells, and synergizes with IL-17 in the production of human β-defensin 2, an antimicrobial and chemotactic protein highly overexpressed by psoriatic keratinocytes. This study reveals a novel mechanistic interaction between Th1 and IL-17+ T cells, challenges the view that Th1 cells suppress Th17 development through IFN-{gamma}, and suggests that Th1 and IL-17+ T cells may collaboratively contribute to human autoimmune diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by the Dermatology Foundation (to A.B. and J.E.G.), the National Psoriasis Foundation (to A.B.), the American Skin Association (to J.E.G.), Grant AR052889 from the National Institute of Arthritis, Musculoskeletal, and Skin Diseases (to J.T.E.), and Grant CA99985 from the National Cancer Institute (to W.Z.).

2 I.K. and A.T.B. contributed equally to this work.

3 Address correspondence and reprint requests to Dr. Weiping Zou, Department of Surgery, University of Michigan Health Systems, 1150 West Medical Center Drive or Dr. James T. Elder, Department of Dermatology, University of Michigan Medical School, 1500 East Medical Center Drive, Ann Arbor, MI 48109. E-mail addresses: wzou{at}med.umich.edu or jelder{at}med.umich.edu

4 Abbreviations used in this paper: siRNA, small interfering RNA; HBD, human β-defensin.


Related articles in The JI:

IN THIS ISSUE

The JI 2008 181: 4431-4432. [Full Text]  



This article has been cited by other articles:


Home page
EndocrinologyHome page
I. Horie, N. Abiru, Y. Nagayama, G. Kuriya, O. Saitoh, T. Ichikawa, Y. Iwakura, and K. Eguchi
T Helper Type 17 Immune Response Plays an Indispensable Role for Development of Iodine-Induced Autoimmune Thyroiditis in Nonobese Diabetic-H2h4 Mice
Endocrinology, November 1, 2009; 150(11): 5135 - 5142.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Kryczek, M. Banerjee, P. Cheng, L. Vatan, W. Szeliga, S. Wei, E. Huang, E. Finlayson, D. Simeone, T. H. Welling, et al.
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Blood, August 6, 2009; 114(6): 1141 - 1149.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Ortega, S. Fernandez-A, J. M. Carrillo, P. Romero, I. J. Molina, J. C. Moreno, and M. Santamaria
IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
J. Leukoc. Biol., August 1, 2009; 86(2): 435 - 443.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Curtis, S. S. Way, and C. B. Wilson
IL-23 Promotes the Production of IL-17 by Antigen-Specific CD8 T Cells in the Absence of IL-12 and Type-I Interferons
J. Immunol., July 1, 2009; 183(1): 381 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Guo, D. Cobb, and R. B. Smeltz
T-bet Inhibits the In Vivo Differentiation of Parasite-Specific CD4+ Th17 Cells in a T Cell-Intrinsic Manner
J. Immunol., May 15, 2009; 182(10): 6179 - 6186.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
R. P. Nair, J. Ding, K. C. Duffin, C. Helms, J. J. Voorhees, G. G. Krueger, A. M. Bowcock, G. R. Abecasis, and J. T. Elder
Psoriasis Bench to Bedside: Genetics Meets Immunology
Arch Dermatol, April 1, 2009; 145(4): 462 - 464.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.